Jacobs Bruce N. (CIK 1821074) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell KYMR (1,500 shares), Buy KYMR (61,378 shares), Sell KYMR (1,700 shares), Sell KYMR (1,100 shares), Sell KYMR (4,110 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 1,500 | $165,810 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Buy | 61,378 | $327,145 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 1,700 | $189,664 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 1,100 | $124,067 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 4,110 | $469,311 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 51,375 | $5.9M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 7,971 | $923,178 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 6,153 | $719,862 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 3,200 | $376,649 |
| 2026-06-03 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Buy | 12,653 | $26,318 |
| 2026-05-19 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Buy | 15,000 | $31,200 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 2,039 | $178,922 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Buy | 17,650 | $0 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 1,424 | $126,024 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 4,113 | $368,772 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 492 | $41,328 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 1,437 | $123,266 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 447 | $38,719 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 2,519 | $214,216 |
| 2025-09-17 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Buy | 79,220 | $164,778 |
| 2025-09-17 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 79,220 | $4.0M |
| 2025-04-01 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Buy | 25,000 | $52,000 |
| 2025-03-03 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 1,281 | $39,711 |
| 2025-03-03 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Buy | 30,000 | $0 |
| 2025-03-03 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Sell | 5,754 | $174,519 |
Source: SEC Form 4 filings · as of 2026-07-02